Company / Operating Cash Flow per Share
Anixa Biosciences Inc Operating Cash Flow per Share History
FY2014-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.24
FY2024
5-year range
-$0.24 / -$0.16
FY2020-FY2024
Trend
-12.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-0.39 in FY2017 to $0.16 in FY2016.
Based on SEC 10-K filings.
-0.24 in FY2024.
Declined from $-0.16 to $-0.24 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating cash flow per share decreased 12.1% year-over-year.
- Peak operating cash flow per share was recorded in FY2016.
- Lowest operating cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.24 | -12.1% |
| FY2023 | -$0.21 | -27.8% |
| FY2022 | -$0.16 | +29.5% |
| FY2020 | -$0.23 | -3.2% |
| FY2019 | -$0.23 | +1.2% |
| FY2018 | -$0.23 | +40.8% |
| FY2017 | -$0.39 | -347.3% |
| FY2016 | $0.16 | +157.7% |
| FY2015 | -$0.27 | -1677.9% |
| FY2014 | -$0.02 | -274.6% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026